Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_assertion type Assertion NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_head.
- NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_assertion description "[Methylation analysis of these CpG islands in a panel of 50 human prostate carcinoma specimens and 24 normal controls revealed miR-132 to be methylated in 42% of human cancer cases in a manner positively correlated to total Gleason score and tumor stage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_provenance.
- NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_assertion evidence source_evidence_literature NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_provenance.
- NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_assertion SIO_000772 22310291 NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_provenance.
- NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_assertion wasDerivedFrom befree-20150227 NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_provenance.
- NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_assertion wasGeneratedBy ECO_0000203 NP993419.RA-tXT519O4kB-SM-_05qEfEP2JiJj_1X952D2EYLIUzc130_provenance.